A novel synthetic route to α-galactosyl ceramides and isoglobotrihexosylceramide (iGb3), which can activate NKT cells, was developed by exploiting a di-tert-butylsilylene-directed α-selective galactosylation procedure.
通过利用二叔丁基
硅烯指导的α选择性半
乳糖基化程序,开发了一种合成α-半
乳糖苷脂和异半乳三糖基脂(biGb3)的新型合成路线,这些化合物能够激活NKT细胞。